Study explores the clinical manifestations, risk factors, and 90-day mortality outcomes in adults hospitalized with RSV or ...

The respiratory syncytial virus (RSV) vaccine (Abrysvo) was linked with fewer hospitalizations and emergency department (ED) ...

The RSV vaccine Abrysvo was highly effective against hospital and ED encounters in a large cohort of older adults with comorbidities and immunocompromising conditions.

A multi-state study, published in The Lancet, is one of the first real world data analyses of the effectiveness of the ...

A large new study says the RSV vaccine is 80% effective at preventing hospitalization in older adults due to complications from the illness, and works just as well at protecting them from death or ...

Adults get a cold an average of two to three times a year ... A nasal swab, or a sample collected by inserting a saltwater solution into the nose and gently suctioning it out, may be used to test for ...

As the leaves change and the air turns crisp, fall officially marks the onset of “sick season.”With the arrival of cooler ...

Although RSV usually causes mild illness with cold-like symptoms, the infection can cause severe respiratory illness in infants, young children, older adults, and people with weakened immune systems ...

This lack of testing amplifies the misdiagnosis of RSV, as its symptoms are so similar to other, more common respiratory viruses like flu. A lack of recognition can also be seen in older adults ...

vaccine effectiveness against RSV-associated hospitalisations and emergency department encounters among adults aged 60 years and older in the USA, October, 2023, to March, 2024: a test-negative ...

What is this silent virus that endangers Filipino Seniors with comorbidities? Respiratory Syncytial Virus (RSV) is not just another cold or flu—it is potentially life- threatening for ...